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Summary
Objective: The aim of this study was to evaluate bone metabolism in patients with spontaneous osteonecrosis (ON) of the medial femoral
condyle.
Method: In 22 consecutive patients, undergoing total knee arthroplasty, biochemical markers of bone metabolism were measured in aspirates
from cancellous bone and in samples obtained simultaneously from peripheral blood. Specimens of the medial femoral condyle were available
for histologic examination and the lesion size, assessed on radiographs, was compared with the results from bone turnover measurements.
Twenty patients with osteoarthritis (OA) of the knee served as a control. Bone-speciﬁc alkaline phosphatase (bone ALP), osteocalcin (OC),
procollagen type I N-terminal propeptide (PINP), and C-terminal cross-linking telopeptide (ICTP) were studied.
Results: Mean serum levels of analytes were not different in patients with ON and OA. The serum concentrations averaged 16.2 vs 13.3 ng/
mL (OC), 10.2 vs 12.1 ng/mL (bone ALP), 4.6 vs 4.1 ng/mL (ICTP), and 33.2 vs 40.4 ng/mL (PINP) in patients with ON and OA, respectively. In
samples obtained from cancellous bone, mean concentrations of all markers were elevated signiﬁcantly when compared to serum levels. The
mean marker concentrations in samples obtained from cancellous bone were 33.8 vs 43.3 ng/mL (OC), 34.6 vs 37.3 ng/mL (bone ALP), 64.8
vs 36.1 ng/mL (ICTP, PZ 0.02), and 208.0 vs 176.2 ng/mL (PINP) in patients with ON and OA, respectively. The lesion size was at mean
440.5G 275.8 mm2 in knees with ON and did not correlate with either serum or bone concentrations of all markers tested (PO 0.1).
Conclusion: The marked elevation of markers in samples obtained from cancellous bone pointed at increased turnover in both diseases when
compared to healthy individuals. In line with histologic ﬁndings of necrosis of subchondral bone, focal degradation of collagen type I was more
pronounced in knees with ON. Mean serum concentrations of all markers, however, were not different from healthy individuals and thus did not
provide any useful clue in the diagnosis spontaneous ON.
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Measurement of collagen type I metabolites [C-terminal
cross-linking telopeptide (ICTP) and N-terminal propeptide
(PINP)] has attracted considerable attention as a means of
determining collagen type I metabolism1e3. In synovial ﬂuid,
concentrations of collagen type I metabolites and osteocal-
cin (OC) were correlated directly with the disease process in
rheumatoid arthritis (RA) and osteoarthritis (OA)4,5. Levels
of chondroitin 6-sulfate (C6S) in synovial ﬂuid of patients
with spontaneous osteonecrosis (ON) of the knee were
reported to be markedly elevated when compared to
patients with medial OA6. Since its ﬁrst description in 1968
by Ahlbeck et al.7 various attempts have been made to
further identify the origin and complex nature of ON of the
medial femoral condyle. Clinically, the disease was found to
follow a four-stage course, ﬁnally leading to articular
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Initially, plain radiography is non-diagnostic, however, with
the advent of magnetic resonance imaging (MRI), signal
alterations indicative of bone marrow edema are observed
in early-stage ON10,11. Drilling of cancellous lesions has
been advocated in these patients, in order to reduce
elevated intramedullary pressure9. In more advanced
stages surgical management including osteotomy, bone
grafting, unicompartmental arthroplasty, and total arthro-
plasty (TKA) has proven effective12. Histologic ﬁndings in
the subchondral zone of the osteonecrotic lesions comprise
lacunae of bone resorption and necrosis of bone marrow
cells, suggesting a general preponderance of degradation
processes with only limited new bone formation8,13.
Serum levels of ICTP have been shown to reﬂect
degradation of collagen type I in various bone pathologies
including RA3, rapidly destructive OA of the hip14, and
neuro-osteoarthropathy of the foot15. Thus, evaluation of
serum ICTP levels seems to be a promising approach for
investigation of spontaneous ON of the knee. We pro-
spectively evaluated bone turnover in a cohort of patients
with spontaneous ON of the knee. Patients with OA of the
knee were examined as a control group.6
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We studied 22 knees (12 right and 10 left) in 22
consecutive patients (19 women and 3 men) undergoing
TKA for treatment of spontaneous ON of the medial femoral
condyle. Twenty patients (17 women and 3 men) with OA of
the knee (grade 4, according to classiﬁcation of Kellgren
and Lawrence) served as controls. Mean age of the patients
with ON was 72.6 years (range 52e90 years) and the
average duration of symptoms was 10.1G 5.7 months
(range 4e26 months). Patients with OA were at mean 73.8
years old (range 57e97 years) and had had symptomatic
knees for at mean 34.2G 14.5 months (Table I). None of
the patients had a history of corticosteroid medication, nor
did any of the patients suffer from RA or a rare disorder
such as sickle cell anemia and Gaucher’s disease. One
patient with spontaneous ON was an alcoholic with an
enlarged liver and a pathologic lipid proﬁle. Medication
affecting bone metabolism such as bisphosphonates,
calcium or vitamin D substitutes, or hormone replacement
therapy was not present in any patient. Duration of the
postmenopausal period was similar in both groups of
patients (27.2 years in females with ON vs 28.6 years in
women with OA). Six patients with ON of the knee had
undergone previous surgery of the affected knee including
arthroscopy, core decompression, and autologous cartilage
and bone grafting. In patients with spontaneous ON, the
Hospital for Special Surgery knee score16 was mean
55.4G 14.2 points (range 34e75, normalZ 100) vs
49.2G 16.8 points in patients with OA (Table I). The
preoperative radiographs were reviewed to determine the
size and stage of progression of ON lesions. The area of
the necrotic lesion was measured using the method by
Muheim and Bohne17. The greatest width on anteroposte-
rior view was multiplied by the greatest length on the lateral
view. Measurements were performed digitally on a ‘‘Magic
View’’ workstation (Siemens, Erlangen, Germany). MRI was
available for all patients with ON before surgery.
Peripheral blood samples (10 mL) were obtained from
a cubital vein after overnight fasting prior to surgery. Values
of OC (ELSA-Osteo, CIS bio Int, Gif-sur Yvette, France) and
bone-speciﬁc alkaline phosphatase (bone ALP) (Tandem-
ostase, Hybritech, San Diego, CA) were evaluated using the
assays given. Concentrations of ICTP and PINP were
assessed using radioimmunoassays supplied by Orion
Diagnostica (FIN-02101 Espoo, Finland). All tests were
identical to assays used in a previous study on healthy
patients18. Patients referred to as healthy controls18 were
younger (mean age 44.1 years, range 15e74 years) than
the patients of the present study. Hence, data on the
postmenopausal status of the 11 female patients from the
previous study18 are not comparable to the present study.However, bone marrow signals of areas, from which
samples of cancellous bone were obtained, were normal in
all patients excluding bony pathologies18. Data on weight
and height were similar in both groups (ON vs OA), although
patients referred to as healthy controls18 were insigniﬁcantly
taller (mean height 173.0 cm) and weighed less (mean
weight 75.2 kg) than patients of the present study.
All knee joints were accessed using a standard anterio-
medial approach. Aspirates from cancellous bone were
obtained from the femoral condyle using a needle (Oto-
lenghyl-Set, Heintel, Vienna, Austria). The resected por-
tions of medial femoral condyles of osteonecrotic knees
were ﬁxed in Schaffer’s ﬂuid and thereafter embedded in
parafﬁn. In 18 patients with ON, specimens were available
for histologic evaluation. Thereafter, the prosthesis (LCS,
DePuy, Johnson & Johnson, Warsaw, USA) was inserted
without the use of cement in patients with ON and OA,
respectively.
Written informed consent was obtained from each
patient. The data were recorded and calculated on
a personal computer using ‘‘Statview’’ statistical software
(SAS, Adept Science, Institute Inc., Letchworth, UK). Non-
parametric tests (ManneWhitney rank test) and Spear-
man’s rank correlation coefﬁcient were used. Statistical
signiﬁcance was set at P! 0.05.
Results
FINDINGS OF THE BONE METABOLIC EVALUATION
Mean serum levels of all bone turnover markers are
shown in Table II(A). Mean serum levels were not different
for any of the markers, moreover, comparison with healthy
individuals18 lacked statistical signiﬁcance (PO 0.1) for both
groups. In samples obtained from cancellous bone, mean
concentrations of all markers were elevated signiﬁcantly
when compared to serum levels [Table II(B)]. Except for
ICTP, concentrations of biochemical markers did not differ
among both groups (PZ 0.02). The mean bone to serum
ratios are given in Table III. Again, bone to serum ratios of
ICTP were increased signiﬁcantly (PZ 0.02) in patients with
ON when compared to patients with OA of the knee. Data on
the individual values of bone to serum ratios of patients with
ON, OA, and healthy controls are provided in Fig. 1(AeC).
When compared with healthy individuals18, bone to serum
ratios of all markers were increased signiﬁcantly (P! 0.05)
in patients with ON and OA, respectively. Correlation with
lesion size, assessed on preoperative radiographs, lacked
statistical signiﬁcance for all markers regardless of their
source. Biochemical markers reﬂecting osteoblast activity
were not clearly correlated with lesion size (PO 0.1) andTable I
Baseline characteristics of patients with spontaneous ON or OA of the knee, and healthy individuals
Parameters Knees with ON
(nZ 22)
Knees with OA
(nZ 20)
Normals*
(nZ 27)
Sex (f/m) 19/3 17/3 11/16
Age (years) 72.6G 10.7 73.8G 11.5 44.1G 15.3
Weight (kg) 76.2G 8.7 78.4G 7.9 75.2G 9.2
Height (cm) 170.2G 6.8 168.5G 7.7 173.0G 7.2
Duration of symptoms (months) 10.1G 5.7 34.2G 14.5 3.6G 2.5
Previous surgery (knees) 6 13 0
Preoperative knee score (pts) 55.4G 14.2 49.2G 16.8 e
*Results of healthy individuals (18).
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Markers of bone turnover in patients with spontaneous ON or OA of the knee, and healthy individuals
Biochemical marker (ng/mL) Knees with ON
(nZ 22)
Knees with OA
(nZ 20)
Normals*
(nZ 27)
(a) Mean serum levelsGSD
OC 16.2G 10.4 13.3G 9.6 16.1G 14.2
Bone ALP 10.2G 7.4 12.1G 7.2 11.7G 10.4
ICTP 4.6G 1.6 4.1G 1.5 3.9G 1.6
PINP 36.2G 19.2 40.3G 22.1 50.0G 59.6
(b) Mean bone levelsGSD
OC 33.8G 27.8 43.3G 29.8 17.8G 15.8
Bone ALP 34.6G 20.3 37.3G 23.4 11.9G 8.9
ICTP 64.8G 36.1y 36.1G 16.1 8.3G 3.9
PINP 208.0G 140.2 176.2G 134.8 108.8G 100.2
yPZ 0.02 vs OA knees.
*Results of healthy individuals (18).correlation of lesion size with bone or serum concentrations
of ICTP also lacked statistical signiﬁcance (PZ 0.18 for
bone levels and PZ 0.28 for serum levels).
MACROSCOPIC AND HISTOLOGIC FINDINGS
The pathological material available for study consisted of
18 portions of the medial femoral condyle. Segmental
necrosis with collapse of the overlying articular cartilage
and irregular defects in articular cartilage were seen. The
necrotic tissue in the ﬂoor of these lesions was grayish-white
and mostly of soft consistency, representing necrotic bone-
detritus. The contour of the medial femoral condyle was
irregular or ﬂattened in all specimens. The osteonecrotic
segments characteristically consisted of bone trabeculae
with empty lacunae and a band of ﬁbrovascular granulation
tissue of variable thickness, with focal areas of osteoclastic
and histiocytic resorption of the dead tissue (Fig. 2). A
subchondral insufﬁciency fracture was seen in two knees.
FINDINGS OF THE RADIOLOGIC EVALUATION
The meanG SD width of the ON lesions was
18.3G 5.4 mm (range 12e29) and the mean length of the
lesions was 20.9G 7.1 mm (range 15e45). The areas of
the lesions ranged from 170 mm2 to 1440 mm2 (mean
440.5G 275.8 mm2). MRI was performed in all patients with
ON showing a rupture of the articular cartilage in 12 knees
or absence of articular cartilage in 10 knees. Signal
alterations (low signal intensity on T1-weighted images
corresponding to areas of high signal intensity on fat-
suppressed T2-weighted images) indicative of perifocal
bone marrow edema were present to a variable extent in all
knees with ON lesions.
Table III
Mean bone to serum ratios in patients with spontaneous ON or OA
of the knee, and healthy individuals
B/S analytes Knees with ON
(nZ 22)
Knees with OA
(nZ 20)
Normals*
(nZ 27)
OC 2.1G 2.6 3.2G 3.3 1.1G 1.1
Bone ALP 3.4G 4.4 3.1G 3.0 1.2G 0.6
ICTP 14.1G 7.6# 9.8G 6.1 2.2G 0.8
PINP 5.8G 8.7 4.4G 6.7 2.3G 1.6
B/S ratioZ bone to serum ratio.
#PZ 0.02 vs OA knees.
*Results of healthy individuals (18).Discussion
In this study, we investigated biochemical markers of
bone metabolism in serum of patients with spontaneous ON
and with OA of the knee. Despite numerous attempts to
elucidate pathophysiologic mechanisms and etiologic fac-
tors, the origin and complex nature of spontaneous ON of
the medial femoral condyle remain unclear5,9. Pathogeneti-
cally, the disease process may be related, in part, to trauma
with microfractures and subsequent ON or primary vascular
insufﬁciency8,13. Some authors favor the hypothesis that
the primary event leading to spontaneous ON of the knee is
a subchondral insufﬁciency fracture and that the localized
ON seen in association with the disease is the result of
a fracture13. Yamamoto and Bullough19 reevaluated a series
of 14 patients, 64% of whom having histological changes
consistent with a subchondral insufﬁciency fracture and
associated focal ON. In accordance with histological
ﬁndings of insufﬁciency fractures in ON of the femoral
head, Bullough13 suggested that the cause of these
fractures was weakness of osseous structures, resulting
from osteoporosis or metabolic disorders and that osteo-
necrotic areas rather represent a secondary phenomenon.
In the present study, however, presence of a subchondral
fracture was conﬁrmed in only two specimens of 18 knees
with spontaneous ON. This ﬁnding is in contrast to the
reported rate of Yamamoto and Bullough19 and renders
a traumatic explanation unlikely in the majority of our
patients. On the other hand, the strong association between
vascular insufﬁciency and occurrence of spontaneous ON
supports the existence of a causal relation20. When
evaluating intra- and extraosseous blood supply to the
distal femoral condyles, Reddy and Frederick20 were able to
show that, in contrast to the lateral femoral condyle, the
intraosseous supply to the medial femoral condyle appears
to consist only of a single nutrient vessel supplying the
subchondral bone with an apparent watershed area of
limited supply. In the animal model, elevated levels of
plasminogen activator inhibitor, being induced by a single
administration of low-dose lipopolysaccharide, have been
shown to cause ON of the medial femoral condyle in
rabbits21. Furthermore, venous stasis and increased intra-
medullary pressure in the medial femoral condyle, which
could possibly lead to decreased arteriovenous pressure
and hence favor development of spontaneous ON, have
been demonstrated in a previous study22.
The rationale for assessment of biochemical markers of
bone turnover in spontaneous ON of the knee was based
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Fig. 1. These graphs show the individual values of bone to serum ratios in patients with spontaneous ON (A) and OA (B) of the knee. (C)
The graph shows the individual values of bone to serum ratios in healthy controls18.on previous observations using these markers for detection
or monitoring of focal bony pathologies such as bone
marrow edema syndrome of the hip and rapidly destructive
OA of the hip14,23,24. However, markers of bone turnover in
patients with spontaneous ON of the knee have not been
reported so far. Increased levels of C6S have been
demonstrated in synovial ﬂuid of patients with ON of the
knee when compared to patients with medial compartmen-
tal OA (grades 2 and 3)6. In our patients, serum levels of allmarkers were not different in patients with ON or OA. Yet,
the marked elevation of markers in samples obtained from
cancellous bone pointed at increased turnover in both
diseases with a preponderance of collagen type I degrada-
tion in knees with ON. The question arises why serum
levels of ICTP were not reﬂecting the focal increase of
degradation of collagen type I in osteonecrotic lesions.
When measuring serum concentrations of bone metabolic
processes, interpretation of marker concentrations has to
720 C. E. Berger et al.: Spontaneous ON of the kneeFig. 2. Photomicrograph of an osteonecrotic lesion (stain, Giemsa, original magniﬁcation,!40). Rupture and collapse of the articular cartilage
are seen adjacent to necrotic bone in the subchondral area (arrows). Necrotic bone marrow is surrounded by ﬁbrovascular proliferation
(granulation tissue).be made with regard to two major aspects. Firstly, a general
increase of bone metabolism can possibly render interpre-
tation more difﬁcult and, secondly, focal processes need to
be sufﬁciently active to have an impact on systemic
concentrations23. A general increase of bone turnover
was not present in our patients, because mean serum
levels did not differ from healthy controls18. However, it can
be speculated that, despite the 14-fold increase of ICTP
levels in samples obtained from cancellous bone, these
changes were not sufﬁcient to affect peripheral blood
concentrations.
Garnero et al.25 have shown two distinctive enzymatic
pathways for the two type I collagen fragments ICTP
and CTX. While ICTP was demonstrated to arise pre-
dominantly through non-cathepsin K enzymatic cleavages
by enzymes such as matrix-metalloproteinases (MMPs),
CTX seems to reﬂect bone remodeling pathways dominated
by cathepsin K. Our study is limited in that regard and
hence, by assessment of ICTP alone, additional information
on the pathogenesis of ON and concentrations of CTX
cannot be provided. However, elevated levels of MMP3 and
increased molar ratios of MMP3/tissue inhibitor of MMP1
have been observed in synovial ﬂuid of patients with ON of
the femoral head, indicating the existence of a causal
relation26,27. When compared to patients with OA of the hip,this elevation was even more pronounced in patients with
ON of the femoral head27. These observations seem to
justify the use of ICTP as degradation marker in the present
study of ON of the knee. Nevertheless, it remains unclear,
why, unlike Saito’s ﬁnding of elevated levels of C6S in
knees with lesions that covered more than 40% of the
condyle6, our results could not demonstrate a clear
correlation between ICTP levels and lesion size.
In the animal model, resorption of necrotic bone during
revascularization could be prevented by treatment with
bisphosphonates28,29. Furthermore, these agents are cur-
rently investigated as a potential treatment for disease
modiﬁcation in patients with OA30 and have been used
successfully in patients with bone marrow edema syndrome
of the hip and in aseptic ON in children31,32. Although the
exact mechanism of action is not yet fully understood,
a possible bisphosphonate-mediated physicochemical in-
hibition of hydroxyapatite dissolution might reduce the
solubility of the mineralized matrix and thereby stabilize
bone structure. It is therefore conceivable that patients with
ON may beneﬁt from treatment with bisphosphonates.
In conclusion, mean serum concentrations of all
markers were not different from healthy individuals and
thus did not provide any useful clue in the diagnosis of
spontaneous ON.
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